196 related articles for article (PubMed ID: 30030494)
1. Clinical tumour sequencing for precision oncology: time for a universal strategy.
Cheng ML; Berger MF; Hyman DM; Solit DB
Nat Rev Cancer; 2018 Sep; 18(9):527-528. PubMed ID: 30030494
[TBL] [Abstract][Full Text] [Related]
2. The changing approach for identifying hereditary colorectal cancer syndromes.
Laghi L; Ricciardiello L
Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):593-594. PubMed ID: 32651554
[No Abstract] [Full Text] [Related]
3. Microsatellite instability and mismatch repair deficiency in the era of precision immuno-oncology.
Mann SA; Cheng L
Expert Rev Anticancer Ther; 2020 Jan; 20(1):1-4. PubMed ID: 31842633
[No Abstract] [Full Text] [Related]
4. Precision oncology: East meets West.
Subbiah V; Rodon J; Yap TA
Int J Cancer; 2018 May; 142(9):1734-1737. PubMed ID: 29243227
[No Abstract] [Full Text] [Related]
5. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
Blumenthal GM; Mansfield E; Pazdur R
JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
[No Abstract] [Full Text] [Related]
6. High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond.
Edsjö A; Russnes HG; Lehtiö J; Tamborero D; Hovig E; Stenzinger A; Rosenquist R;
J Intern Med; 2024 Jun; 295(6):785-803. PubMed ID: 38698538
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the Future of Oncology and Precision Medicine through Data Science.
Zaravinos A
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891982
[TBL] [Abstract][Full Text] [Related]
8. Precision oncology in patients with nonmetastatic disease: emerging reality or illusion.
Antoniou P; Ziogas DE; Mitsis M; Roukos DH
Future Oncol; 2019 Jun; 15(16):1805-1810. PubMed ID: 31170806
[No Abstract] [Full Text] [Related]
9. The Architecture of a Precision Oncology Platform.
Laganà A
Adv Exp Med Biol; 2022; 1361():1-22. PubMed ID: 35230680
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
[No Abstract] [Full Text] [Related]
11. Precision oncology in the age of integrative genomics.
Kumar-Sinha C; Chinnaiyan AM
Nat Biotechnol; 2018 Jan; 36(1):46-60. PubMed ID: 29319699
[TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
Ziogas DE; Kyrochristos ID; Roukos DH
Expert Rev Med Devices; 2018 Jan; 15(1):1-3. PubMed ID: 29284319
[No Abstract] [Full Text] [Related]
13. Bringing Precision Medicine to Community Oncologists.
Cancer Discov; 2017 Jan; 7(1):6-7. PubMed ID: 27864232
[TBL] [Abstract][Full Text] [Related]
14. Genomic profiling in oncology clinical practice.
Rodríguez N; Viñal D; Rodríguez-Cobos J; De Castro J; Domínguez G
Clin Transl Oncol; 2020 Sep; 22(9):1430-1439. PubMed ID: 31981077
[TBL] [Abstract][Full Text] [Related]
15. The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform.
Ciombor K; Jones J; Strickler J; Bekaii-Saab T; Wu C
Oncology (Williston Park); 2021 Sep; 35(9):553-559. PubMed ID: 34524770
[No Abstract] [Full Text] [Related]
16. [The new challenge in oncology: Next-generation sequencing and its application in precision medicine].
Calabria I; Pedrola L; Berlanga P; Aparisi MJ; Sánchez-Izquierdo D; Cañete A; Cervera J; Millán JM; Castel V
An Pediatr (Barc); 2016 Nov; 85(5):273.e1-273.e7. PubMed ID: 27349697
[TBL] [Abstract][Full Text] [Related]
17. [Microsatellite instability and cancer: from genomic instability to personalized medicine].
Collura A; Lefevre JH; Svrcek M; Tougeron D; Zaanan A; Duval A
Med Sci (Paris); 2019; 35(6-7):535-543. PubMed ID: 31274083
[TBL] [Abstract][Full Text] [Related]
18. Universal Genomic Testing: The next step in oncological decision-making or a dead end street?
Holch JW; Metzeler KH; Jung A; Riedmann K; Jost PJ; Weichert W; Kirchner T; Heinemann V; Westphalen CB
Eur J Cancer; 2017 Sep; 82():72-79. PubMed ID: 28648701
[TBL] [Abstract][Full Text] [Related]
19. Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.
Ghazani AA; Oliver NM; St Pierre JP; Garofalo A; Rainville IR; Hiller E; Treacy DJ; Rojas-Rudilla V; Wood S; Bair E; Parello M; Huang F; Giannakis M; Wilson FH; Stover EH; Corsello SM; Nguyen T; Rana HQ; Church AJ; Lowenstein C; Cibulskis C; Amin-Mansour A; Heng J; Brais L; Santos A; Bauer P; Waldron A; Lo P; Gorman M; Lydon CA; Welch M; McNamara P; Gabriel S; Sholl LM; Lindeman NI; Garber JE; Joffe S; Van Allen EM; Gray SW; Ja Nne PA; Garraway LA; Wagle N
Genet Med; 2017 Jul; 19(7):787-795. PubMed ID: 28125075
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Microsatellite Instability from Next-Generation Sequencing Data.
Renault V; Tubacher E; How-Kit A
Adv Exp Med Biol; 2022; 1361():75-100. PubMed ID: 35230684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
